{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tHt1cQuwWV\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23780\/\">2011\u5e7412\u670829\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/23780\/embed\/#?secret=tHt1cQuwWV\" width=\"600\" height=\"338\" title=\"\u300a Animal Health News &#038; Notes for December 29, 2011 \u300b\u2014Brakke Consulting Website\" data-secret=\"tHt1cQuwWV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer freindly version ************************************ Brakke Consulting&rsquo;s Animal Health News &amp; Notes for December 29, 2011 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news&nbsp; 2012 Overview registration earnings news Neogen other news Abaxis (feline heartworm) Abaxis (Lyme disease) Avivagen Bioheart Bioniche MedTrade Mueller Medical NDI Stemlogix Vet-Stem Virbac &nbsp; *********************************** COMPANY EARNINGS RELEASES &nbsp; &gt; Neogen Corporation announced results for the second quarter of FY 2012 ended Nov. 30. Revenues increased 2% from the previous year&rsquo;s second quarter to $45 million. Net income for the quarter was $5.2 million, a decline of 15% compared to the prior year&rsquo;s second quarter. Neogen&rsquo;s Animal Safety Division revenues increased to $22.8 million from $22.6 million in the same period last year (company press release) &nbsp; ************************************ COMPANY NEWS RELEASES &nbsp; &gt; The FDA reported it has approved Virbac&rsquo;s treatment for canine ear infections, Easotic. The prescription-only product contains hydrocortisone, miconazole and gentamycin. (Animal Pharm) &nbsp; &gt; Bioniche Animal Health announced that it has entered into two distribution agreements to expand its product offerings in North America.&nbsp; The first agreement is with MedTrade Products, which will provide a number of equine and companion animal health products based on its Celox (chitosan) woundcare technology for exclusive distribution by Bioniche in Canada. The second agreement is withView Full Post;"}